Assenagon Asset Management S.A. Amicus Therapeutics, Inc. Transaction History
Assenagon Asset Management S.A.
- $65.1 Billion
- Q3 2025
A detailed history of Assenagon Asset Management S.A. transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 1,848,454 shares of FOLD stock, worth $16.5 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,848,454
Previous 3,533,854
47.69%
Holding current value
$16.5 Million
Previous $20.2 Million
28.07%
% of portfolio
0.02%
Previous 0.03%
Shares
13 transactions
Others Institutions Holding FOLD
# of Institutions
304Shares Held
332MCall Options Held
396KPut Options Held
249K-
Vanguard Group Inc Valley Forge, PA29.4MShares$262 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA29.1MShares$259 Million0.03% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$217 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY18MShares$160 Million1.88% of portfolio
-
William Blair Investment Management, LLC Chicago, IL14.6MShares$130 Million0.24% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $2.5B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...